JZ
Jonathan Zalevsky
DELAYED 1 MONTH
Chief R&D Officer
NEKTAR THERAPEUTICS
Filings
2
Companies
1
Latest
Jul 24, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
48
NKTRCLUSTER 2
NEKTAR THERAPEUTICS
Jonathan Zalevsky
Chief R&D Officer
Sale
$13.0K
199 sh
May 21 10:26 PM
May 19, 2026